NCT03190824 2019-04-16
Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma
Syneos Health
Phase 2 Unknown
Clinical Trials
3 trialsNCT01864759 2017-08-29
Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma
Institut Català d'Oncologia
Phase 1 Completed
NCT00116363 2008-04-01
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
Introgen Therapeutics
Phase 2 Unknown